Ascendis Health Overview
- Founded
- 2008
- Status
- Public
- Stock Symbol
- ASC
- Investments
- 20
- Share Price
- $0.05
- (As of Friday Closing)
Ascendis Health General Information
Description
Ascendis Health Limited is a drug manufacturer that produces and distributes health products for the human, animal, and plant markets. Ascendis Health has four segments: Phyto-Vet, Consumer Brands, Pharma-Med, and International. The Phyto-Vet segment supplies health and care products to the plants and animal market. The Consumer brands segment sells vitamins and minerals, ayurvedic products, herbal products, weight management products, and sports nutritional supplements. The Pharma-Med segment provides prescription medicine and medical devices. The International segment sells the aforementioned products abroad. The company earns the majority of its revenue in South Africa.
Contact Information
Primary Industry
Pharmaceuticals
Other Industries
Drug Delivery
Stock Exchange
JSE
Primary Office
- PostNet, Suite 252
- Private Bag X21
- Johannesburg, Gauteng 2191
- South Africa
+27 011 000 0000
Ascendis Health Stock Performance
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.05 | $0.05 | $0.02 - $0.13 | $22.7M | 478M | 806K | -$0.13 |
Ascendis Health Financials Summary
|
In Thousands, USD |
TTM 30-Jun-2020 | FY 2020 30-Jun-2020 | FY 2019 30-Jun-2019 | FY 2018 30-Jun-2018 |
|---|---|---|---|---|
| EV | 410,929 | 410,929 | 540,439 | 773,956 |
| Revenue | 417,185 | 417,185 | 390,540 | 391,499 |
| EBITDA | 14,243 | 14,243 | (70,862) | 56,171 |
| Net Income | (63,815) | (63,815) | (331,507) | 20,006 |
| Total Assets | 707,863 | 707,863 | 795,699 | 1,149,634 |
| Total Debt | 417,900 | 417,900 | 412,427 | 407,175 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
Ascendis Health Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
This information is available in the PitchBook Platform. To explore Ascendis Health‘s full profile, request access.
Request a free trialAscendis Health Executive Team (6)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Mark Sardi | Chief Executive Officer | ||
| Kieron Futter | Chief Financial Officer | ||
| Andy Sims | Company Secretary & Chief Risk Officer |
Ascendis Health Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
This information is available in the PitchBook Platform. To explore Ascendis Health‘s full profile, request access.
Request a free trialAscendis Health Investments & Acquisitions (20)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 00000 0000 | 29-Nov-2017 | 000000000000000000 | 000.00 | Medical Supplies | |
| 000 0000 000000 | 02-Jun-2017 | 000000000000000000 | 000.00 | Pharmaceuticals | 0000000 0000000 00.0 |
| 000 0000000 000000 | 01-Jun-2017 | 000000000000000000 | 000.00 | Pharmaceuticals | 0000000 0000000 00.0 |
| 00000 (00000 00000 | 01-Apr-2017 | 000000000000000000 | 000.00 | Pharmaceuticals | |
| Scitec Nutrition | 26-Aug-2016 | Merger/Acquisition | 00000 | Beverages | 0000000 0000000 00.0 |
Ascendis Health Subsidiaries (9)
| Company Name | Industry | Location | Founded |
|---|---|---|---|
| SOLAL Technologies | Food Products | Johannesburg, South Africa | 2009 |
| 000 0000 000000 | Pharmaceuticals | Bucuresti, Romania | 0000 |
| 0000000000 000000 | Other Pharmaceuticals and Biotechnology | Umhlanga Rocks, South Africa | 0000 |
| 00000000000 0000 0 | Medical Supplies | Johannesburg, South Africa | 0000 |
| 00000 0000 0000000 | Personal Products | Rivonia, South Africa | 0000 |
Ascendis Health Exits (4)
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| 000000 000000000 | 26-Aug-2016 | 000000000000000000 | 00000 | Completed |
|
| 00000000 | 01-Feb-2016 | 000000000000000000 | 000.00 | Completed |
|
| 00000000 0000 & 00 | 11-Jul-2013 | 0000000000 | 000.00 | Completed |
|
| Efekto | 01-Sep-2011 | Buyout/LBO | Completed |
|